Two Sigma Securities’s Arcadia Biosciences RKDA Stock Holding History

Two Sigma Securities’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-354	Closed	-$3.83K	–	3163
2022 Q4	$3.83K	Sell	354 -751	-68%	-$10.7K	﹤0.01%	2479
2022 Q3	$23K	Buy	1,105 +579	+110%	+$19.8K	﹤0.01%	2286
2022 Q2	$21K	Sell	526 -1,065	-67%	-$49K	﹤0.01%	1954
2022 Q1	$89K	Buy	1,591 +1,184	+291%	+$56.5K	﹤0.01%	1820
2021 Q4	$17K	Buy	+407	New	+$26.5K	﹤0.01%	1430
2021 Q3	–	Sell	-273	Closed	-$32K	–	1881
2021 Q2	$32K	Buy	+273	New	+$29.8K	﹤0.01%	1428

Other funds holding RKDA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Securities's RKDA Position: Q1 2023 in Review

Two Sigma Securities sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 354 shares — an estimated $3.83K sold.

Two Sigma Securities first reported a position in RKDA in Q2 2021 and held it in 6 quarters. The position peaked at $89K in Q1 2022. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

Two Sigma Securities reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 354 Arcadia Biosciences shares in Q1 2023, an estimated $3.83K.
Two Sigma Securities first reported a position in Arcadia Biosciences in Q2 2021 and held it in 6 quarters.
Two Sigma Securities's Arcadia Biosciences position peaked at $89K in Q1 2022.
15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.